These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3209531)

  • 1. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa.
    McNulty CA; Dent JC; Ford GA; Wilkinson SP
    J Antimicrob Chemother; 1988 Nov; 22(5):729-38. PubMed ID: 3209531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens.
    Westblom TU; Duriex DE; Madan E; Belshe RB
    Antimicrob Agents Chemother; 1990 Jan; 34(1):25-8. PubMed ID: 2327758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple crossover study on absorption and excretion of ampicillin, pivampicillin, and amoxycillin.
    Verbist L
    Antimicrob Agents Chemother; 1974 Nov; 6(5):588-93. PubMed ID: 15825310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997.
    Thwaites RT; Frost JA
    J Clin Pathol; 1999 Nov; 52(11):812-4. PubMed ID: 10690169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014.
    Post A; Martiny D; van Waterschoot N; Hallin M; Maniewski U; Bottieau E; Van Esbroeck M; Vlieghe E; Ombelet S; Vandenberg O; Jacobs J
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2101-2107. PubMed ID: 28623550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
    Sugita K; Katouno Y; Uchida H; Kobayashi Y
    Jpn J Antibiot; 2002 Dec; 55(6):771-7. PubMed ID: 12621731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents.
    Grayson ML; Eliopoulos GM; Ferraro MJ; Moellering RC
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):888-9. PubMed ID: 2512133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.
    Rodríguez-Avial I; Rodríguez-Avial C; López O; Culebras E; Picazo JJ
    Int J Antimicrob Agents; 2006 Apr; 27(4):303-6. PubMed ID: 16540293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method].
    Žemličková H; Jakubů V; Marejková M; Urbášková P
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):184-90. PubMed ID: 25412481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against Helicobacter pylori.
    Westblom TU; Duriex DE
    Microbiologica; 1991 Jan; 14(1):37-43. PubMed ID: 2067414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of 16 antimicrobial agents against Helicobacter (Campylobacter) pylori].
    García-Rodríguez JA; García-García MI; García-Sánchez E; García-Sánchez JE; Muñoz Bellido JL
    Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):544-6. PubMed ID: 2490433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Campylobacter coli isolates from Finnish farrowing farms using aminopenicillins: high prevalence of bla(OXA-61) and β-lactamase production, but low MIC values.
    Juntunen P; Heiska H; Hänninen ML
    Foodborne Pathog Dis; 2012 Oct; 9(10):902-6. PubMed ID: 22924522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008.
    Valenza G; Frosch M; Abele-Horn M
    Scand J Infect Dis; 2010; 42(1):57-60. PubMed ID: 20055727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of efflux pump inhibitors on erythromycin, ciprofloxacin, and tetracycline resistance in Campylobacter spp. isolates.
    Kurinčič M; Klančnik A; Smole Možina S
    Microb Drug Resist; 2012 Oct; 18(5):492-501. PubMed ID: 22741576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative sensitivities to antimicrobial agents of Campylobacter pylori and the gastric campylobacter like organism from the ferret.
    Jeffries L; Buckley DE; Blower PR; Plumb JN
    J Clin Pathol; 1987 Oct; 40(10):1265-7. PubMed ID: 3680554
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.
    Hardy DJ; Hanson CW; Hensey DM; Beyer JM; Fernandes PB
    J Antimicrob Chemother; 1988 Nov; 22(5):631-6. PubMed ID: 3209524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications.
    Tanih NF; Okeleye BI; Naidoo N; Clarke AM; Mkwetshana N; Green E; Ndip LM; Ndip RN
    S Afr Med J; 2010 Jan; 100(1):49-52. PubMed ID: 20429489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone and macrolide resistance in Campylobacter jejuni isolated from broiler slaughterhouses in southern Brazil.
    Sierra-Arguello YM; Perdoncini G; Morgan RB; Salle CT; Moraes HL; Gomes MJ; do Nascimento VP
    Avian Pathol; 2016; 45(1):66-72. PubMed ID: 26925976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat.
    Pandya HB; Agravat HH; Patel JS; Sodagar NR
    Indian J Med Microbiol; 2014; 32(4):408-13. PubMed ID: 25297026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments.
    Juntunen P; Olkkola S; Hänninen ML
    Vet Microbiol; 2011 Jun; 150(3-4):322-30. PubMed ID: 21397412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.